Net loss of Genpharmasec reported to Rs 1.18 crore in the quarter ended September 2025 as against net profit of Rs 0.70 crore during the previous quarter ended September 2024. Sales rose 441.29% to Rs 32.64 crore in the quarter ended September 2025 as against Rs 6.03 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales32.646.03 441 OPM %-1.441.99 - PBDT-0.230.81 PL PBT-0.800.50 PL NP-1.180.70 PL Powered by Capital Market - Live News

Net profit of Genpharmasec declined 18.00% to Rs 0.82 crore in the quarter ended September 2025 as against Rs 1.00 crore during the previous quarter ended September 2024. Sales rose 446.97% to Rs 31.56 crore in the quarter ended September 2025 as against Rs 5.77 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales31.565.77 447 OPM %1.624.33 - PBDT1.431.07 34 PBT1.391.03 35 NP0.821.00 -18 Powered by Capital Market - Live News

Genpharmasec will hold a meeting of the Board of Directors of the Company on 6 November 2025.Powered by Capital Market - Live News

Genpharmasec announced that the 33rd Annual General Meeting(AGM) of the company will be held on 29 September 2025.Powered by Capital Market - Live News

Genpharmasec will hold a meeting of the Board of Directors of the Company on 2 September 2025.Powered by Capital Market - Live News